On 18 June 2025, Yichang Hec Changjiang Pharmaceutical Co. Ltd. announced a disclosure of internal dealings under Rule 22 of the Hong Kong Code on Takeovers and Mergers. CICC Financial Trading Limited engaged in a derivative contract involving 685,600 reference securities, with a maturity date set for 17 June 2026. CICC Financial Trading Limited, an exempt principal trader connected with the Offeror and owned by China International Capital Corporation Limited, conducted these dealings for its own account.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yichang Hec Changjiang Pharmaceutical Co. Ltd. published the original content used to generate this news brief on June 18, 2025, and is solely responsible for the information contained therein.